Skip to main content
  • Poster presentation
  • Open access
  • Published:

Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy

Tuberculosis (TB) is still a prevalent disease, one third of the population is infected by mycobacterium tuberculosis (MT).Treatment with anti TNF therapies appears to increase the risk for developing TB


To study the occurrence of latent TB (LTB) or tuberculosis disease (TBD) in children with JIA under anti TNF therapy.


Clinical records from pts with JIA ( ILAR´01) under anti-TNF therapy were reviewed, focusing on TB screening prior to biologicals , PPD conversion or TBD diagnosiss.LTB was considered as a PPD (TST) positive (≥ 5 mm), in the abscense of radiological manifestations of TB.


105 JIA pts received one or more anti TNF drugs during the observation. Four of them developed LTB and 3 others TBD.


No extrapulmonar TB or miliary forms were observed. All patients were PPD negative prior to biological agents


No significative difference was found between specific anti TNF and the occurrence of LTB or TBD. In 4 pts, the infectious event occurred after 2 ys of exposure and in two earlier as described in the literature. This data highlights the importance of TB surveillance prior to and during anti-TNF therapy.

Author information

Authors and Affiliations


Rights and permissions

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Espada, G., Giupponi, J. & Cerqueiro, C. Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy. Pediatr Rheumatol 9 (Suppl 1), P72 (2011).

Download citation

  • Published:

  • DOI: